About Rystiggo
ROZANOLIXIZUMAB treats myasthenia gravis, a condition that causes muscles to easily weaken or fatigue. It works by decreasing muscle weakness and loss of movement. It is a monoclonal antibody.
With the Patient Assistance Program from UCB, receive your prescription at no cost if you are eligible.
